Featured Research

from universities, journals, and other organizations

Private Sector Plays A Critical Role In Drug Development, New Report Argues

Date:
June 24, 2008
Source:
Tufts University, Health Sciences
Summary:
A new report examines case histories for thirty-five important pharmaceutical innovations. Skeptics of the private industry assert that the development of new medicines is most attributable to publicly funded sources.

A new report co-authored by Manhattan Institute senior fellow Benjamin Zycher, and Joseph DiMasi, and Christopher-Paul Milne, researchers from the Tufts Center for the Study of Drug Development, examines case histories for thirty-five important pharmaceutical innovations. Skeptics of the private industry assert that the development of new medicines is most attributable to publicly funded sources.

Related Articles


As Marcia Angell, former editor-in-chief of The New England Journal of Medicine, remarked during an interview with PBS News : "Innovation comes mainly from NIH-supported research in academic medical centers. The drug companies do almost no innovation."

In this new study, the authors debunk this assertion and argue that the private sector plays a critical role in drug development.

Key findings include:

  • NIH-sponsored research tends to be concentrated on the basic science of disease biology, biochemistry, and disease processes, the goal of which is to identify biologic targets that might prove vulnerable to drugs yet to be developed.
  • Private sector contributions are weighted heavily toward the applied science of discovering ways to pursue treatments and cures for adverse medical conditions.

The authors conclude that NIH-sponsored and private-sector drug research are complementary to one another and are equally necessary in order to provide patients with better care and treatment.

Benjamin Zycher, Ph.D., is a Senior Fellow at the Manhattan Institute's Center for Medical Progress. He writes extensively on economic and political effects of government regulation and taxation. His research interests include health care policy and the pharmaceutical sector. Benjamin Zycher is available to discuss this report and matters relating to economics and public expenditures.

Joseph A. DiMasi, Ph.D., is Director of Economic Analysis at the Tufts Center for the Study of Drug Development at Tufts University. His research interests include drug development and regulatory review processes, the impact of policies and practices to speed the development and review processes for new drugs, as well as other matters relating to the economics of the pharmaceutical industry.

Christopher--Paul Milne, D.V.M., M.P.H., J.D., is Associate Director at the Tufts Center for the Study of Drug Development at Tufts University. His research interests include the role of outsourcing in drug development, issues relating to the research and development of new treatments, specifically those for serious and life--threatening illnesses, rare disorders and conditions, and neglected diseases of the developing world. He also studies regulatory and policy initiatives related to the Critical Path Initiative.


Story Source:

The above story is based on materials provided by Tufts University, Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

Tufts University, Health Sciences. "Private Sector Plays A Critical Role In Drug Development, New Report Argues." ScienceDaily. ScienceDaily, 24 June 2008. <www.sciencedaily.com/releases/2008/06/080624122554.htm>.
Tufts University, Health Sciences. (2008, June 24). Private Sector Plays A Critical Role In Drug Development, New Report Argues. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2008/06/080624122554.htm
Tufts University, Health Sciences. "Private Sector Plays A Critical Role In Drug Development, New Report Argues." ScienceDaily. www.sciencedaily.com/releases/2008/06/080624122554.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com
Madagascar Working to Contain Plague Outbreak

Madagascar Working to Contain Plague Outbreak

AFP (Nov. 24, 2014) — Madagascar said Monday it is trying to contain an outbreak of plague -- similar to the Black Death that swept Medieval Europe -- that has killed 40 people and is spreading to the capital Antananarivo. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Are Female Bosses More Likely To Be Depressed?

Are Female Bosses More Likely To Be Depressed?

Newsy (Nov. 24, 2014) — A new study links greater authority with increased depressive symptoms among women in the workplace. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins